Epidarex Capital closes over $80 mln for early-stage life science fund
Epidarex Capital has raised over $80 million for a UK-based early-stage life science and health tech venture fund. Its LPs include King's College London, Eli Lilly and Co., European Investment Fund, Scottish Enterprise and Strathclyde Pension Fund.
29 May 2014•3 mins read
